GSK

(GSK)
Sector: Pharmaceuticals & Biotechnology
1,456.00p
9.50p 0.66
Last updated: 16:41:58

Company News Headlines

Date Time Headline Source
29/05/2025 07:00 Transaction in Own Shares RNS
28/05/2025 12:00 GSK stops Phase 3 trial on cUTIs for efficacy RNS
28/05/2025 07:00 Transaction in Own Shares RNS
27/05/2025 07:00 Transaction in Own Shares RNS
23/05/2025 12:16 positive CHMP opinion on Blenrep in EU RNS
23/05/2025 07:00 FDA approves Nucala COPD indication RNS
23/05/2025 07:00 Transaction in Own Shares RNS
22/05/2025 07:00 Transaction in Own Shares RNS
21/05/2025 07:00 Transaction in Own Shares RNS
20/05/2025 15:30 Director/PDMR Shareholding RNS
20/05/2025 07:00 Transaction in Own Shares RNS
19/05/2025 07:00 Blenrep for 2L+ multiple myeloma approved in Japan RNS
19/05/2025 07:00 Transaction in Own Shares RNS
16/05/2025 07:00 Transaction in Own Shares RNS
15/05/2025 07:00 Transaction in Own Shares RNS
14/05/2025 07:00 GSK to acquire efimosfermin RNS
14/05/2025 07:00 Transaction in Own Shares RNS
13/05/2025 15:30 Director/PDMR Shareholding RNS
13/05/2025 12:56 Update on belrestotug development programme RNS
13/05/2025 07:00 Transaction in Own Shares RNS
12/05/2025 15:31 Block listing Interim Review RNS
12/05/2025 07:00 Transaction in Own Shares RNS
09/05/2025 07:00 Transaction in Own Shares RNS
08/05/2025 17:15 Director/PDMR Shareholding RNS
08/05/2025 15:30 Director/PDMR Shareholding RNS
08/05/2025 11:15 Linerixibat GLISTEN pIII trial data at EASL RNS
08/05/2025 07:00 Transaction in Own Shares RNS
07/05/2025 18:22 Result of AGM RNS
07/05/2025 07:00 Transaction in Own Shares RNS
06/05/2025 07:00 Transaction in Own Shares RNS
02/05/2025 07:00 Transaction in Own Shares RNS
01/05/2025 15:30 Director/PDMR Shareholding RNS
01/05/2025 15:00 Total Voting Rights RNS
01/05/2025 07:00 Nucala MATINEE data in COPD published in NEJM RNS
01/05/2025 07:00 Transaction in Own Shares RNS
30/04/2025 07:05 Transaction in Own Shares RNS
30/04/2025 07:00 1st Quarter Results RNS
29/04/2025 07:00 Transaction in Own Shares RNS
28/04/2025 07:00 Transaction in Own Shares RNS
25/04/2025 07:00 Transaction in Own Shares RNS
24/04/2025 07:00 Transaction in Own Shares RNS
23/04/2025 07:00 Transaction in Own Shares RNS
22/04/2025 07:00 Transaction in Own Shares RNS
17/04/2025 16:13 Blenrep licensed by UK MHRA RNS
17/04/2025 15:30 Director/PDMR Shareholding RNS
17/04/2025 07:10 Arexvy now ACIP recommended for 50-59 at risk RNS
17/04/2025 07:05 GSK 5-in-1 meningitis vaccine recommended in US RNS
17/04/2025 07:00 Transaction in Own Shares RNS
16/04/2025 07:00 Transaction in Own Shares RNS
15/04/2025 15:30 Director/PDMR Shareholding RNS